Methotrexate vs Upadacitinib
Compare Methotrexate and Upadacitinib side by side: what they treat, drug class, cost and FDA label information.
| Methotrexate | Upadacitinib | |
|---|---|---|
| Drug class | Folate Analog Metabolic Inhibitor | Janus Kinase Inhibitor |
| Used to treat | Breast neoplasms, Choriocarcinoma, Crohn disease, Esophageal neoplasms, Hydatidiform mole, Juvenile arthritis, Leukemia, Lung neoplasms, Mycosis fungoides, Osteosarcoma, Psoriasis, Rheumatoid arthritis, Stomach neoplasms, Testicular neoplasms | Rheumatoid arthritis |
| Generic price | From $0.16 each, about $4.73 for 30 (2.5 mg tablet); other forms from $0.70 per mL (250 mg/10 mL vial) | No generic price listed |
| Brand price | No brand price listed | Rinvoq: from $229 each, about $6,879 for 30 (30 mg tablet (ER)) |
| Generic savings | Not listed | Not listed |